Precision Cancer Vaccines: Advancing Personalized Immunotherapy

13 Oct 2026

This session will highlight how precision medicine is transforming the development of cancer vaccines, supporting more targeted and individualized strategies for cancer care.

Speakers
Patrick Ott
Patrick Ott, Clinical Director, Professor - Melanoma Center, Dana Farber Cancer Institute, Harvard Medical School